Table 1. Patients characteristics.
| Variable |
Number of cases (%)
|
|
|---|---|---|
| Age | ||
| <50 yr. | 68 | (24) |
| ≥50 yr. | 213 | (76) |
| T stage | ||
| T1 | 91 | (32) |
| T2 | 128 | (46) |
| T3 | 28 | (10) |
| T4 | 31 | (11) |
| Missing data | 3 | (1) |
| N stage | ||
| N0 | 148 | (53) |
| N1 | 73 | (26) |
| N2 | 50 | (18) |
| N3 | 6 | (2) |
| Missing data | 4 | (1) |
| Grade | ||
| G1 | 14 | (5) |
| G2 | 107 | (38) |
| G3 | 85 | (30) |
| Missing data | 75 | (27) |
| HER2 status | ||
| Negative | 182 | (65) |
| Positive | 29 | (10) |
| Missing data | 70 | (25) |
| ER status | ||
| Negative | 120 | (43) |
| Positive | 161 | (57) |
| PgR status | ||
| Negative | 131 | (47) |
| Positive | 150 | (53) |
| Histological type | ||
| Ductal | 191 | (68) |
| Lobular | 51 | (18) |
| Other | 33 | (12) |
| Missing data | 6 | (2) |
| Molecular subtype | ||
| Luminal A | 60 | (21) |
| Luminal B (HER2-) | 38 | (14) |
| Luminal B (HER2+) | 15 | (5) |
| HER2+ | 14 | (5) |
| Triple negative | 56 | (20) |
| Missing data | 98 | (35) |
| TAM-treatment | ||
| Not-treated | 206 | (73) |
| Treated | 75 | (27) |